DongKook Pharmaceutical Co., Ltd. (KOSDAQ:086450)

DongKook Pharmaceutical Revenue

DongKook Pharmaceutical had revenue of 226.81B KRW in the quarter ending September 30, 2025, with 12.91% growth. This brings the company's revenue in the last twelve months to 894.93B, up 13.41% year-over-year. In the year 2024, DongKook Pharmaceutical had annual revenue of 812.17B with 11.10% growth.

• Revenue (ttm): 894.93B
• Revenue Growth: +13.41%
• P/S Ratio: 0.95
• Revenue / Employee: 725.82M
• Employees: 1,233
• Market Cap: 851.38B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	812.17B	81.17B	11.10%
Dec 31, 2023	730.99B	69.35B	10.48%
Dec 31, 2022	661.65B	67.45B	11.35%
Dec 31, 2021	594.19B	35.09B	6.28%
Dec 31, 2020	559.10B	76.82B	15.93%